Strategic Collaborations and M&A Activity: How Industry Partnerships Are Accelerating Innovation and Market Consolidation in Cancer Therapy.
The last decade has been defined by the ascendance of immunotherapy, a revolutionary drug type that leverages the patient's own biological defenses to combat malignancy. This category, which includes checkpoint inhibitors and CAR T-cell therapies, has delivered unprecedented long-term survival rates in previously intractable cancers, solidifying its position as the most impactful driver of...
0 Kommentare 0 Geteilt 119 Ansichten 0 Bewertungen